1. Jeffs RD, Jonas P, Schillinger JF. Surgical correction of vesicoureteral reflux in children with neurogenic bladder. J Urol 1976;115:449-51. PMID:
1263323
2. Seki N, Akazawa K, Senoh K, Kubo S, Tsunoda T, Kimoto Y, et al. An analysis of risk factors for upper urinary tract deterioration in patients with myelodysplasia. BJU Int 1999;84:679-82. PMID:
10510115
3. Sidi AA, Peng W, Gonzalez R. Vesicoureteral reflux in children with myelodysplasia: natural history and results of treatment. J Urol 1986;136(1 Pt 2):329-31. PMID:
3723683
5. López Pereira P, Martinez Urrutia MJ, Lobato Romera R, Jaureguizar E. Should we treat vesicoureteral reflux in patients who simultaneously undergo bladder augmentation for neuropathic bladder? J Urol 2001;165(6 Pt 2):2259-61. PMID:
11371958
6. Engel JD, Palmer LS, Cheng EY, Kaplan WE. Surgical versus endoscopic correction of vesicoureteral reflux in children with neurogenic bladder dysfunction. J Urol 1997;157:2291-4. PMID:
9146655
7. Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003;326:841-4. PMID:
12702614
8. Thüroff JW, Abrams P, Andersson KE, Artibani W, Chapple CR, Drake MJ, et al. EAU Guidelines on Urinary Incontinence. Actas Urol Esp 2011;35:373-88. PMID:
21600674
10. Top T, Sekerci CA, Isbilen-Basok B, Tanidir Y, Tinay I, Isman FK, et al. The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia. Neurourol Urodyn 2017;36:1896-902. PMID:
28090659
11. Sekerci CA, Tanidir Y, Toprak T, Basok BI, Isman F, Simsek F, et al. Value of urinary brain-derived neurotrophic factor levels on the assessment of botulinum toxin type A treatment for neurogenic detrusor overactivity in children with myelodysplasia. J Urol 2019;201:174-80. PMID:
30577408
12. Hascoet J, Peyronnet B, Forin V, Baron M, Capon G, Prudhomme T, et al. Intradetrusor injections of botulinum toxin type A in children with spina bifida: a multicenter study. Urology 2018;116:161-7. PMID:
29522865
14. Lindehall B, Claesson I, Hjälmås K, Jodal U. Effect of clean intermittent catheterisation on radiological appearance of the upper urinary tract in children with myelomeningocele. Br J Urol 1991;67:415-9. PMID:
2032080
16. Merlini E, Beseghi U, De Castro R, Perlasca E, Podesta E, Riccipetitoni G. Treatment of vesicoureteric reflux in the neurogenic bladder. Br J Urol 1993;72:969-71. PMID:
8306168
17. Kondo A, Otani T. Correction of reflux with the ureteric crossover method. Clinical experience in 50 patients. Br J Urol 1987;60:36-8. PMID:
3620844
18. Granata C, Buffa P, Di Rovasenda E, Mattioli G, Scarsi PL, Podesta E, et al. Treatment of vesico-ureteric reflux in children with neuropathic bladder: a comparison of surgical and endoscopic correction. J Pediatr Surg 1999;34:1836-8. PMID:
10626867
19. Perez-Brayfield M, Kirsch AJ, Hensle TW, Koyle MA, Furness P, Scherz HC. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol 2004;172(4 Pt 2):1614-6. PMID:
15371773
20. Neel KF, Salem M, Soliman S. Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report. J Pediatr Urol 2008;4:124-6. PMID:
18631907
21. Schurch B, Schmid DM, Stöhrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000;342:665. PMID:
10702067
22. Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 2008;53:275-87. PMID:
17988791
24. Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005;174:196-200. PMID:
15947626
25. Mascarenhas F, Cocuzza M, Gomes CM, Leão N. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients. Neurourol Urodyn 2008;27:311-4. PMID:
17914742